Literature DB >> 19078427

Dermatomyositis-like illness following kava-kava ingestion.

S Guro-Razuman1, P Anand, Q Hu, R Mir.   

Abstract

Kava-kava is an herbal medication, most commonly used to treat anxiety. It is derived from the roots of the pepper plant, Piper methysticum. A 47-year-old white woman presented with a rash and proximal muscle weakness 2 weeks after ingestion of kava-kava. Her creatine kinase level was elevated at 8654 U/L, and an electromyogram showed a myopathic pattern. Skin biopsy and muscle biopsy samples showed changes consistent with dermatomyositis. The patient improved with prednisone and discontinuation of the kava-kava. No similar association between kava-kava ingestion and dermatomyositis has been reported previously.

Entities:  

Year:  1999        PMID: 19078427     DOI: 10.1097/00124743-199912000-00008

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  5 in total

1.  Pacific island 'Awa (Kava) extracts, but not isolated kavalactones, promote proinflammatory responses in model mast cells.

Authors:  Lori M N Shimoda; Christy Park; Alexander J Stokes; Henry Halenani Gomes; Helen Turner
Journal:  Phytother Res       Date:  2012-04-04       Impact factor: 5.878

2.  A systematic review of the safety of kava extract in the treatment of anxiety.

Authors:  Clare Stevinson; Alyson Huntley; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

3.  Identification and characterization of kava-derived compounds mediating TNF-alpha suppression.

Authors:  Michael P Pollastri; Adrian Whitty; Jamie Cassidy Merrill; Xiaoren Tang; Trent D Ashton; Salomon Amar
Journal:  Chem Biol Drug Des       Date:  2009-06-16       Impact factor: 2.817

4.  Inflammatory sebotropic reaction associated with kava kava ingestion.

Authors:  Zoe O Brown-Joel; Erica S Colleran; Mary Seabury Stone
Journal:  JAAD Case Rep       Date:  2018-04-30

5.  Kava-induced acute cutaneous toxicity: An increasingly recognized characteristic clinicohistologic pattern.

Authors:  Alexandra K Rzepecki; Jenna Wald; Bijal Amin; Edison Leung; Evan Choi; Yevgeniy Balagula
Journal:  JAAD Case Rep       Date:  2018-11-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.